Kristie Blum
Physician · Emory University School of Medicine
Credentials: · · · · ·
History
Research
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2013 · 1,914 citations
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
New England Journal of Medicine · 2013 · 1,377 citations
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib
New England Journal of Medicine · 2014 · 1,075 citations
- JB
51 papers
33 papers
- JJ
27 papers
24 papers
- MG
23 papers
- JF
22 papers
22 papers
- BK
21 papers
Grants
- 2015–2020
Development of a Comprehensive Research Program in Mantle Cell Lymphoma in the Ibrutinib Era
National Cancer Institute · K24
Contact PI · $886.3K · Emory University
- 2015–2020
Dual Targeting of XPO1 and BTK in B Cell Malignancies
National Cancer Institute · R01
PI · $764.6K · Ohio State University
- 2014–2019
OSU as Network Lead Academic Participating Site for the NCI NCTN
National Cancer Institute · U10
PI · $5.4M · Ohio State University
- 2008–2012
Modulating the Tumor Micro-Environment in CLL Using Flavopiridol and Lenalidomide
National Cancer Institute · R21
Contact PI · $675K · Ohio State University
Clinical trials
- 2022–2028
Principal investigator · Recruiting · Phase 2
Emory University
- 2013–2017
Principal investigator · Terminated · Phase 2
Ohio State University Comprehensive Cancer Center
- 2011–2016
Principal investigator · Completed · Phase 2
Ohio State University Comprehensive Cancer Center
- 2011–2025
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)